A novel metabolic gene signature-based nomogram to predict overall survival in breast cancer

BACKGROUND: Breast cancer risk prediction is often based on clinicopathological characteristics despite the high heterogeneity derived from gene expression. Metabolic alteration is a hallmark of cancer, and thus, the integration of a metabolic signature with clinical parameters is necessary to predi...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xi, Zhou, Zhi-Rui, Fang, Yan, Ding, Shuning, Lu, Shuangshuang, Wang, Zheng, Wang, Hui, Chen, Xiaosong, Shen, Kunwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033348/
https://www.ncbi.nlm.nih.gov/pubmed/33842588
http://dx.doi.org/10.21037/atm-20-4813

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8033348/
https://www.ncbi.nlm.nih.gov/pubmed/33842588
http://dx.doi.org/10.21037/atm-20-4813

Ejemplares similares